Prescribers with restrictions
Based on data from TPP Alberta, CPSA can impose prescribing conditions on physicians that restrict their prescriptive authority under certain situations. These listings and conditions are below.
Pharmacists can contact TPP Alberta using the contact form at the bottom of this page for guidance if questions arise or advice is required in specific circumstances.
Any prescribing condition effective before March 1st, 2021 does not include Antibiotics.
Physicians
Adams, James (Jim)
CPSA Registration #: 008831
Date effective: Nov. 4, 2025
Restrictions:
Restricted from prescribing Type 1 opioids and Type 2 opioids monitored by the Alberta Tracked Prescription Program.
Alshigagi, Emadalden
CPSA Registration #: 019582
Date effective: May 1, 2024
Restriction:
Restricted from prescribing all Type 1 and Type 2 medications monitored by the Alberta Tracked Prescription Program, excluding antibiotics. Exception: Alberta TPP medications, Type 1 and Type 2, prescriptions that included refills in the original prescription that were initiated prior to this restriction shall only be permitted until July 28, 2024. As of July 29, 2024, no exceptions shall apply and no prescription refills shall be permitted.
Barrow, John Lincoln
CPSA Registration #: 004774
Date effective: May 31, 2024
Restriction:
Restricted from prescribing OAT medications for the management of Opioid Use Disorder (with the exception of Buprenorphine/Naloxone).
Ben Milud Jalutha, Bashir
CPSA Registration #: 020987
Date effective: April 17, 2026
Restriction:
TPP Type 1 medications, TPP Type 2 opioids (including buprenorphine and buprenorphine/naloxone), benzodiazepines, and Z-drugs.
Collett, Franklin Dean
CPSA Registration #: 005473
Date effective: Nov. 29, 2019
Restriction:
Prescribing restrictions apply. Prescribing restrictions for the following medications: Tracked Prescription Program medications, anabolic steroids, methylphenidate, barbiturates, codeine containing drugs, amphetamine or amphetamine like appetite suppressants, benzodiazepines and other anxiolytics, hypnotics and sedatives, and muscle relaxants.
Galloway, Lyle
CPSA Registration #: 011239
Date effective: June 23, 2025
Restriction:
Restricted from prescribing ketamine.
Han, William (Wei)
CPSA Registration #: 016501
Date effective: Jan. 15, 2023
Restriction:
Restricted from prescribing all Type 1 and Type 2 medications monitored by the Alberta Tracked Prescription Program (TPP), and cannabinoids. Excludes antimicrobials.
Hauptman, Robert
CPSA Registration #: 009841
Date effective: July 8, 2024
Restriction:
Restricted from prescribing all Alberta TPP medications Type 1, and Type 2, with the exclusion of antibiotics, gabapentinoids, stimulants and Orexin antagonists. Permitted to prescribe Alberta TPP medications Type 2 containing codeine or tramadol for the treatment of acute, episodic pain for up to fourteen (14) days per three-month period for patients already in Dr. Hauptman's practice panel.
Haws, Jolene
CPSA Registration #019747
Date effective: April 14, 2026
Restriction:
All TPP Alberta Type 1 medications and TPP Alberta Type 2 opioids.
Kordyban, Michael
Restriction:
Voluntarily surrenders all TPP Alberta pads under his control and shall not request resumption of prescribing of medications requiring the use of a TPP Alberta pad, in any manner.
CPSA Registration #: 007774
Date effective: Dec. 2, 2015
Lavallee, Melvyn
CPSA Registration #: 005498
Date effective: March 18, 2026
Restriction:
Type 1 and Type 2 medications monitored by the Alberta Tracked Prescription Program except for antibiotics; gabapentin, pregabalin, sustained release stimulants with a documented diagnosis of attention deficit disorder; and benzodiazepines for the treatment of epilepsy.
Lopez, Roehl
CPSA Registration #: 014516
Date effective: Dec. 23, 2025
Restriction:
Restricted from prescribing all TPP Type 1 medications and certain Type 2 medications, being Type 2 Opioids, Z-drugs and Orexin Antagonists. Also restricted from prescribing benzodiazepines except where there are indications of epilepsy.
McAlpine, Brian Douglas
CPSA Registration #: 007062
Date effective: March 11, 2022
Restriction:
Restricted from prescribing TPP (Tracked Prescription Program) Alberta Type 1 and Type 2 medications (not including antibiotics) except for emergencies, in which case the prescription shall be for no more than a 3-day supply.
McPeak, Brian K.
CPSA Registration #: 011422
Date effective: Aug. 28, 2019
Restriction:
Prescribing of Type 1 TPP Alberta medications restricted to inpatient facilities.
McKennitt, Daniel William
CPSA Registration #: 016729
Date effective: May 10, 2023
Restriction:
Will not prescribe medications monitored by TPP Alberta (Type 1 and 2 medications), including Tramadol, with the exception of antibiotics.
Mentz, Helena Johanna
CPSA Registration #: 021313
Date effective: May 2, 2024
Restriction:
Prescribing restrictions apply. May maintain currently active prescriptions for Alberta TPP Type 1 and Type 2 medications initiated prior to this restriction, but is otherwise restricted from prescribing all Alberta TPP Type 1 and Type 2 medications with the exclusion of stimulants, gabapentinoids, and antibiotics.
Mitchell, Oluwatomi (Tomi)
CPSA Registration #: 029878
Date effective: Aug. 16, 2018
Restriction:
Restricted from prescribing Opioids.
Oyama, Sonnie
CPSA Registration #: 021134
Date effective: Feb. 8, 2022
Restriction:
Type 1 and Type 2 opioid and benzodiazepine medications monitored by the Tracked Prescription Program (TPP), includes all methadone and cannabinoids but does not apply to antimicrobials, Z-drugs and stimulants tracked by the TPP.
Rosenstock, Carl
CPSA Registration #: 007352
Date effective: Oct. 8, 2020
Restriction:
Restricted to prescribing TPP Alberta medications to patients attached to my practice as of October 1, 2020. Restricted to prescribing opioids only to existing patients with a diagnosis of malignancy. Restricted to prescribing benzodiazepines only to existing patients with diagnoses of seizure disorders or malignancy.
Swart, Johan
CPSA Registration #: 016993
Date effective: Dec. 14, 2017
Restriction:
Restricted from prescribing Type 1 Medications as per the TPP Alberta program.